New molecular and therapeutic insights into canine diffuse large B-cell lymphoma elucidates the role of the dog as a model for human disease.
作者信息
Aresu Luca, Ferraresso Serena, Marconato Laura, Cascione Luciano, Napoli Sara, Gaudio Eugenio, Kwee Ivo, Tarantelli Chiara, Testa Andrea, Maniaci Chiara, Ciulli Alessio, Hillmann Petra, Bohnacker Thomas, Wymann Matthias P, Comazzi Stefano, Milan Massimo, Riondato Fulvio, Rovere Giulia Dalla, Giantin Mery, Giannuzzi Diana, Bertoni Francesco
机构信息
Dipartimento di Scienze Veterinarie, Università degli Studi di Torino, Italy
Dipartimento di Biomedicina Comparata e Alimentazione, Università degli Studi di Padova, Italy.
出版信息
Haematologica. 2019 Jun;104(6):e256-e259. doi: 10.3324/haematol.2018.207027. Epub 2018 Dec 13.
Abstract
摘要
相似文献
1
New molecular and therapeutic insights into canine diffuse large B-cell lymphoma elucidates the role of the dog as a model for human disease.对犬弥漫性大B细胞淋巴瘤的新分子和治疗见解阐明了狗作为人类疾病模型的作用。
Haematologica. 2019 Jun;104(6):e256-e259. doi: 10.3324/haematol.2018.207027. Epub 2018 Dec 13.
2
Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients.肿瘤相关中性粒细胞与弥漫性大B细胞淋巴瘤患者的不良预后相关。
Blood Cancer J. 2018 Jul 5;8(7):66. doi: 10.1038/s41408-018-0099-y.
3
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.使用Lymph2Cx检测法评估HIV相关弥漫性大B细胞淋巴瘤的起源细胞亚型。
Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15.
4
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.DNA 甲基化分析揭示了肿瘤发生的共同特征，并定义了犬弥漫性大 B 细胞淋巴瘤的表观遗传预后亚型。
Sci Rep. 2017 Sep 14;7(1):11591. doi: 10.1038/s41598-017-11724-w.
5
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.弥漫性大 B 细胞淋巴瘤：预后标志物及其对治疗的影响。
Expert Rev Hematol. 2016 May;9(5):471-7. doi: 10.1586/17474086.2016.1146584. Epub 2016 Feb 19.
6
Advances in the management of primary mediastinal large B-cell lymphoma.原发性纵隔大B细胞淋巴瘤的管理进展
Clin Adv Hematol Oncol. 2018 Jan;16(1):33-34.
7
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.结外弥漫性大 B 细胞淋巴瘤：分子特征、预后和中枢神经系统复发风险。
Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8.
8
Report of the first workshop on prognostic factors in large-cell lymphomas.大细胞淋巴瘤预后因素首次研讨会报告
Ann Oncol. 1991 Feb;2 Suppl 2:213-7. doi: 10.1007/978-1-4899-7305-4_34.
9
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.采用临床检测对弥漫性大 B 细胞淋巴瘤进行 DNA/RNA 靶向综合基因组分析。
Blood Cancer J. 2018 Jun 12;8(6):60. doi: 10.1038/s41408-018-0089-0.
10
Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.原发性皮肤弥漫性大B细胞淋巴瘤：临床病理亚型的预后意义
Am J Surg Pathol. 2003 Dec;27(12):1538-45. doi: 10.1097/00000478-200312000-00006.
引用本文的文献
1
Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.犬B细胞淋巴瘤的免疫谱分析揭示了预后标志物的跨物种保守性。
Sci Rep. 2025 Aug 4;15(1):28385. doi: 10.1038/s41598-025-13389-2.
2
Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology-Pathology Working Group.犬原发性淋巴结淋巴瘤的诊断与分类：肿瘤病理学工作组共识
Vet Comp Oncol. 2025 Sep;23(3):331-345. doi: 10.1111/vco.13064. Epub 2025 May 19.
3
Expanding the Spectrum of Canine Diffuse Large B-Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis.通过全基因组测序分析扩展犬弥漫性大B细胞淋巴瘤基因畸变谱
Vet Comp Oncol. 2025 Sep;23(3):346-357. doi: 10.1111/vco.13059. Epub 2025 May 4.
4
Expression Profile of Twelve Transcripts as a Supporting Tool for the Molecular Characterization of Canine Cutaneous Mast Cell Tumors at Diagnosis: Association with Histological Grading and Clinical Staging.十二种转录本的表达谱作为犬皮肤肥大细胞瘤诊断时分子特征分析的辅助工具：与组织学分级和临床分期的关联
Genes (Basel). 2025 Mar 14;16(3):340. doi: 10.3390/genes16030340.
5
What We Know and Do Not Yet Know About the Canine Model of Lymphoma in Human Medicine-The Current State of Knowledge.我们在人类医学中对犬淋巴瘤模型的已知与未知——当前的知识状况
Cancers (Basel). 2025 Feb 10;17(4):596. doi: 10.3390/cancers17040596.
6
Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison.连续转录组分析：在详细的T细胞和B细胞亚型比较之前对正常犬和犬淋巴瘤进行的比较分析。
Front Vet Sci. 2025 Jan 22;11:1473421. doi: 10.3389/fvets.2024.1473421. eCollection 2024.
7
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma.溴结构域蛋白作为B细胞非霍奇金淋巴瘤的潜在治疗靶点。
Cell Biosci. 2024 Nov 23;14(1):143. doi: 10.1186/s13578-024-01326-1.
8
Predictive value of RNAscope hybridization and p53 immunohistochemistry for mutational status in canine diffuse large B-cell lymphoma.RNAscope杂交和p53免疫组织化学对犬弥漫性大B细胞淋巴瘤突变状态的预测价值
Vet Q. 2024 Dec;44(1):1-9. doi: 10.1080/01652176.2024.2403453. Epub 2024 Sep 16.
9
The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification.K9 淋巴瘤检测法可以对犬类淋巴瘤进行遗传亚群分类，从而改善风险分类。
Sci Rep. 2024 Aug 12;14(1):18687. doi: 10.1038/s41598-024-69716-6.
10
Thinking Outside the Box: Indirect Myc Modulation in Canine B-Cell Lymphoma.跳出框框思考：犬B细胞淋巴瘤中的间接Myc调节
Animals (Basel). 2024 May 15;14(10):1466. doi: 10.3390/ani14101466.
本文引用的文献
1
Genetics of diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的遗传学。
Blood. 2018 May 24;131(21):2307-2319. doi: 10.1182/blood-2017-11-764332. Epub 2018 Apr 17.
2
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.PQR309 是一种新型的双重 PI3K/mTOR 抑制剂，在淋巴瘤的单药治疗和联合治疗中具有抗肿瘤活性。
Clin Cancer Res. 2018 Jan 1;24(1):120-129. doi: 10.1158/1078-0432.CCR-17-1041. Epub 2017 Oct 24.
3
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.DNA 甲基化分析揭示了肿瘤发生的共同特征，并定义了犬弥漫性大 B 细胞淋巴瘤的表观遗传预后亚型。
Sci Rep. 2017 Sep 14;7(1):11591. doi: 10.1038/s41598-017-11724-w.
4
Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma.犬淋巴瘤：不仅仅是形态学诊断——我们对弥漫性大 B 细胞淋巴瘤的认识。
Front Vet Sci. 2016 Aug 31;3:77. doi: 10.3389/fvets.2016.00077. eCollection 2016.
5
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.新型布鲁顿酪氨酸激酶（BTK）抑制剂阿卡替尼在犬B细胞非霍奇金淋巴瘤模型中的临床前评估
PLoS One. 2016 Jul 19;11(7):e0159607. doi: 10.1371/journal.pone.0159607. eCollection 2016.
6
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4.选择性小分子诱导的BET溴结构域蛋白BRD4降解
ACS Chem Biol. 2015 Aug 21;10(8):1770-7. doi: 10.1021/acschembio.5b00216. Epub 2015 Jun 16.
7
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.BET 溴结构域抑制剂 OTX015 影响临床前 B 细胞肿瘤模型中的致病途径，并与靶向药物协同作用。
Clin Cancer Res. 2015 Apr 1;21(7):1628-38. doi: 10.1158/1078-0432.CCR-14-1561. Epub 2015 Jan 26.
8
Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.犬和人 B 细胞淋巴瘤中 TRAF3 的遗传失活。
Blood. 2015 Feb 5;125(6):999-1005. doi: 10.1182/blood-2014-10-602714. Epub 2014 Dec 2.
9
Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma.随机、安慰剂对照、双盲化疗免疫治疗临床试验在弥漫性大 B 细胞淋巴瘤犬模型中进行。
Clin Cancer Res. 2014 Feb 1;20(3):668-77. doi: 10.1158/1078-0432.CCR-13-2283. Epub 2013 Dec 3.
10
Comparative RNA-Seq and microarray analysis of gene expression changes in B-cell lymphomas of Canis familiaris.比较犬科动物 B 细胞淋巴瘤的基因表达变化的 RNA-Seq 和微阵列分析。
PLoS One. 2013 Apr 4;8(4):e61088. doi: 10.1371/journal.pone.0061088. Print 2013.
Zotero 插件